Vesugen

Early human Anti-Aging & Longevity 2 sources

Vesugen is a synthetic tripeptide (Lys-Glu-Asp or KED) developed as a blood vessel bioregulator. Research indicates it supports vascular health by improving microcirculation, enhancing endothelial cell function, and potentially mitigating age-related vascular changes like atherosclerosis.

01Dosing reference

Amount

10-20 mg/day (oral) or 5-10 mg (SubQ)

Frequency

1-2 times daily

Cycle

10-30 days, repeated every 4-6 months

Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

Endothelial Targeting

The KED tripeptide binds to specific DNA sequences in vascular endothelial cells.

Gene Expression Regulation

It stimulates the synthesis of proteins necessary for the repair and regeneration of the vascular wall.

Vascular Normalization

This leads to improved elasticity of blood vessels, reduced arterial stiffness, and enhanced microcirculation.

03Human evidence

Improved microcirculation and reduced symptoms in patients with atherosclerosis and hypertension.

Clinical studies in older adults showed improved lipid profiles, decreased vascular stiffness, and better overall cardiovascular function when used as an adjunct therapy.

Enhanced recovery and functional capacity in patients with ischemic heart disease.

Observational trials in Russia demonstrated improved exercise tolerance and reduced angina episodes in elderly patients.

04Preclinical evidence

Normalization of vascular endothelial cell function under stress.

In vitro studies on human vascular cells showed that the KED peptide increases cell proliferation and reduces apoptosis in aging cell cultures.

Reduction in the progression of atherosclerotic plaques.

Animal models of atherosclerosis demonstrated that administration of the peptide slowed the development of vascular lesions and improved arterial compliance.

05What is known vs. unknown

Reasonably established

Vesugen is a synthetic tripeptide (Lys-Glu-Asp) belonging to the Khavinson bioregulator family.
It is designed to mimic the effects of the natural vascular peptide complex, Ventfort.
Research primarily focuses on its ability to restore endothelial function and improve microcirculation.
It is frequently studied in the context of gerontology for combating age-related cardiovascular decline.

Unknowns & limits

There is a lack of large-scale, double-blind, placebo-controlled clinical trials in Western populations.
Long-term safety and efficacy data outside of Russian clinical studies remain limited.
The exact molecular binding sites and comprehensive pharmacokinetics are not fully characterized in international literature.

06Safety & regulatory context

Regulatory statusVesugen is generally reported to be well-tolerated in Russian clinical studies, with no severe adverse effects or allergic reactions noted. However, it is not approved by the FDA or EMA for the treatment, prevention, or cure of any medical condition. It is primarily available as a dietary supplement or research chemical. Potential side effects are not extensively documented but could include mild gastrointestinal upset (if taken orally) or injection site reactions (if administered subcutaneously).

07Compared with Ventfort

Vesugen vs. Ventfort

Key difference

Ventfort is a natural peptide complex extracted from the blood vessels of young animals, whereas Vesugen is a synthesized tripeptide (KED) designed to replicate its effects.

When researchers discuss each

Researchers discuss Ventfort when a broader spectrum of natural vascular peptides is desired, while Vesugen is preferred for a targeted, highly purified, and standardized synthetic approach.

08Glossary

Endothelium

The thin layer of cells that lines the interior surface of blood vessels, playing a crucial role in vascular health.

Bioregulator

A substance, often a short peptide, that helps to normalize and regulate the function of specific organs or tissues at the cellular level.

Atherosclerosis

A disease in which plaque builds up inside arteries, narrowing them and limiting blood flow.

09Knowledge check

Q1What is the primary target tissue for Vesugen?

Q2How does Vesugen differ from Ventfort?

Q3Which limitation in the dossier most directly affects how confidently Vesugen study results can be applied to Western populations?

Q4According to the dossier, in which research context would investigators be most likely to choose Vesugen rather than Ventfort?

Q5Which statement best reflects Vesugen’s safety and regulatory context as described in the dossier?

10Sources

More in Anti-Aging & Longevity

See all

Epitalon

Anti-Aging & Longevity

Human clinical

Epitalon is a synthetic tetrapeptide designed to mimic the effects of epithalamin, a natural polypeptide produced in the pineal gland. Research suggests it can activate telomerase, elongate telomeres, regulate melatonin production, and potentially extend lifespan in animal models.

5-10 mg/day

SS-31 (Elamipretide)

Anti-Aging & Longevity

Human clinical

SS-31, also known as elamipretide, is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane. It helps restore mitochondrial function, reduce oxidative stress, and improve cellular energy production. Research has heavily focused on its potential for treating heart failure, mitochondrial myopathies, and age-related cellular decline.

2-4 mg/day

FOXO4-DRI

Anti-Aging & Longevity

Preclinical only

FOXO4-DRI is an engineered peptide designed to selectively induce apoptosis (programmed cell death) in senescent cells. Research in animal models suggests it can clear these 'zombie cells' by disrupting the interaction between the FOXO4 and p53 proteins, potentially reversing signs of aging and restoring tissue function.

1-3 mg/day (theoretical research dose)

Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.